Volume: 13 Issue: 1
Year: 2025, Page: 42-47, Doi: https://doi.org/10.47799/pimr.1301.09
Received: June 22, 2024 Accepted: April 10, 2025 Published: April 21, 2025
Introduction: Late-onset depression (LOD), often linked to immune dysfunction and vascular factors, presents distinct treatment challenges compared to early-onset depression. Predicting treatment outcomes remains difficult. We hypothesized that baseline levels of C-reactive protein (CRP), an inflammatory marker, may correlate with antidepressant response in individuals experiencing their first episode of LOD. Methods: This prospective study recruited subjects aged >60 years presenting with their first depressive episode (ICD-10 DCR criteria). Baseline assessments included clinical evaluation, serum CRP measurement (mg/L), and depression severity using the 17-item Hamilton Depression Rating Scale (HAMD-17). Participants received standard antidepressant treatment (Escitalopram) for 8 weeks, after which HAMD-17 was reassessed. Treatment response was defined as ≥50% reduction in HAMD-17 score from baseline. Results: Of 64 eligible participants, twenty-five participants (mean age 64.7±5.8 years; baseline HAMD-17 score 18±3) completed the 8-week follow-up. The overall antidepressant response rate was 24% (n=6 responders). Responders (n=6) had a mean baseline HAMD-17 score of 16±1.9, while non-responders (n=19) had a mean baseline score of 18.6±3.1. The mean baseline CRP level was significantly higher in non-responders (6.27 ± 1.58 mg/L) compared to responders (3.80 ± 1.40 mg/L) (p = 0.002). A significant negative correlation was observed between baseline CRP levels and antidepressant response (r = –0.588, p = 0.02). Conclusions: In this preliminary study of older adults with first-episode LOD, elevated baseline CRP levels were associated with a poorer response to an 8-week course of standard antidepressant therapy suggesting that systemic inflammation may be a potential predictive biomarker for treatment outcomes in this population.
Keywords: C-reactive protein, Late onset depression, Antidepressant
2022. GBD 2019 Mental Disorders Collaborators. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9(2):137–150.
Barua, Ankur, Ghosh, Mihir Kumar, Kar, Nilamadhab & Basilio, Mary Anne . 2011. Prevalence of depressive disorders in the elderly. Annals of Saudi Medicine 31(6):620–624.
Panza, Francesco, Frisardi, Vincenza, Capurso, Cristiano, D'Introno, Alessia, Colacicco, Anna M., Imbimbo, Bruno P., Santamato, Andrea, Vendemiale, Gianluigi, Seripa, Davide, Pilotto, Alberto, Capurso, Antonio & Solfrizzi, Vincenzo . 2010. Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum? The American Journal of Geriatric Psychiatry 18(2):98–116.
Pushap, Agar Chander, Sudershan, Srishty, Bhagat, Sheetal, Sachdeva, Pallavi, Younis, Mohd, Sudershan, Amrit & Kumar, Parvinder . 2025. Depression and its major risk factors in India: A narrative review. Advanced Neurology 1–31.
Szymkowicz, Sarah M, Gerlach, Andrew R, Homiack, Damek & Taylor, Warren D . 2023. Biological factors influencing depression in later life: role of aging processes and treatment implications. Translational Psychiatry 13(1):1–16.
Blazer, Dan G, Hybels, Celia F, Fillenbaum, Gerda G & Pieper, Carl F . 2005. Predictors of Antidepressant Use Among Older Adults: Have They Changed Over Time? American Journal of Psychiatry 162(4):705–710.
Steinert, Christiane, Hofmann, Mareike, Kruse, Johannes & Leichsenring, Falk . 2014. The prospective long-term course of adult depression in general practice and the community. A systematic literature review. Journal of Affective Disorders 152-154:65–75.
Reddy, M S . 2010. Depression: The Disorder and the Burden. Indian Journal of Psychological Medicine 32(1):1–2.
Whyte, Ellen M, Dew, Mary Amanda, Gildengers, Ariel, Lenze, Eric J, Bharucha, Ashok, Mulsant, Benoit H & Reynolds, Charles F . 2004. Time Course of Response to Antidepressants in Late-Life Major Depression. Drugs & Aging 21(8):531–554.
2006. Questions and Answers about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study — All Medication Levels. https://www.nimh.nih.gov/funding/clinical-research/practical/stard/allmedicationlevels
Reynolds, C F, Frank, E, Kupfer, D J, Thase, M E, Perel, J M, Mazumdar, S & Houck, P R . 1996. Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients. American Journal of Psychiatry 153(10):1288–1292.
Burvill, P . 1994. The outcome of depressive illness in old age. In: Chiu, Edmond & Ames, David , eds. Functional Psychiatric Disorders of the Elderly. (pp. 111-125) Cambridge University Press
Taylor, W D, Aizenstein, H J & Alexopoulos, G S . 2013. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Molecular Psychiatry 18(9):963–974.
Alexopoulos, George S, Bruce, Martha L, Silbersweig, David, Kalayam, Balu & Stern, Emily . 1999. Vascular depression: a new view of late-onset depression. Dialogues in Clinical Neuroscience 1(2):68–80.
Orsolini, Laura, Pompili, Simone, Valenta, Silvia Tempia, Salvi, Virginio & Volpe, Umberto . 2022. C-Reactive Protein as a Biomarker for Major Depressive Disorder? International Journal of Molecular Sciences 23(3):1–39.
Al-harbi, . 2012. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Preference and Adherence 6:369–388.
Su, Shaoyong, Miller, Andrew H, Snieder, Harold, Bremner, J Douglas, Ritchie, James, Maisano, Carisa, Jones, Linda, Murrah, Nancy V, Goldberg, Jack & Vaccarino, Viola . 2009. Common Genetic Contributions to Depressive Symptoms and Inflammatory Markers in Middle-Aged Men: The Twins Heart Study. Psychosomatic Medicine 71(2):152–158.
2003. ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research (ICD-10 DCR). Geneva: World Health Organization. World Health Organization. ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research (ICD-10 DCR). https://apps.who.int/iris/bitstream/handle/10665/37108/9241544554.pdf
Folstein, M F, Folstein, S E & McHugh, P R . 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12(3):189–198.
Dufouil, Carole, Beiser, Alexa, McLure, Leslie A, Wolf, Philip A, Tzourio, Christophe, Howard, Virginia J, Westwood, Andrew J, Himali, Jayandra J, Sullivan, Lisa, Aparicio, Hugo J., Kelly-Hayes, Margaret, Ritchie, Karen, Kase, Carlos S., Pikula, Aleksandra, Romero, Jose R., D’Agostino, Ralph B., Samieri, Cécilia, Vasan, Ramachandran S., Chêne, Genevieve, Howard, George & Seshadri, Sudha . 2017. Revised Framingham Stroke Risk Profile to Reflect Temporal Trends. Circulation 135(12):1145–1159.
Zimmerman, Mark, Martinez, Jennifer H, Young, Diane, Chelminski, Iwona & Dalrymple, Kristy . 2013. Severity classification on the Hamilton depression rating scale. Journal of Affective Disorders 150(2):384–388.
Hamilton, M . 1960. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 23(1):56–62.
Leucht, Stefan, Fennema, Hein, Engel, Rolf, Kaspers–Janssen, Marion, Lepping, Peter & Szegedi, Armin . 2013. What does the HAMD mean? Journal of Affective Disorders 148(2-3):243–248.
Kohli, C, Kishore, J, Agarwal, P & Singh, S V . 2013. Prevalence of Unrecognised Depression Among Outpatient Department Attendees of A Rural Hospital in Delhi, India. Journal of Clinical and Diagnostic Research 7(9):1921–1925.
Spijker, Jan, Graaf, Ron De, Bijl, Rob V, Beekman, Aartjan T F, Ormel, Johan & Nolen, Willem A . 2002. Duration of major depressive episodes in the general population: Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS) British Journal of Psychiatry 181(3):208–213.
Srivastava, Shrikant, Kumar, Ambrish, Khurana, Hitesh, Tiwari, Sarvada Chand & Akbar, Shamsi . 2015. Short-term course and outcome of late-life depression. Journal of Geriatric Mental Health 2(2):96–101.
Ancelin, M-L, Farré, A, Carrière, I, Ritchie, K, Chaudieu, I & Ryan, J . 2015. C-reactive protein gene variants: independent association with late-life depression and circulating protein levels. Translational Psychiatry 5(1):1–8.
Rifai, Nader, Tracy, Russell P & Ridker, Paul M . 1999. Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay. Clinical Chemistry 45(12):2136–2141.
Ridker, Paul M & Cook, Nancy . 2004. Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores. Circulation 109(16):1955–1959.
©2025 (Dheerendra Kumar Mishra) et al. This is an open-access journal, and arƟcles are distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
Mishra DK, Singh UP, Sardesai U. C-Reactive Protein as an Indicator for Antidepressant Response in Late-Onset Depression: A prospective Study. Perspectives in Medical Research. 2025;13(1):42- 47 DOI: 10.47799/pimr.1301.09